Trials / Completed
CompletedNCT04217382
Pre Transplantation Melanoma
Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma. There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet. Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | patient with melanoma pre transplantation | survival time without melanoma recurrence |
Timeline
- Start date
- 2020-02-27
- Primary completion
- 2020-08-31
- Completion
- 2020-08-31
- First posted
- 2020-01-03
- Last updated
- 2021-12-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04217382. Inclusion in this directory is not an endorsement.